Neuromuscular Disorder-Targeting Compound 1
Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome.
Product Specifications
CAS Number
374538-23-5
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/1H-Pyrazolo[3,4-g]quinoline,_4,4a,5,6,7,8,8a,9-octahydro-7-[_methylthio_methyl]-5-propyl-,__4aR,8aR_-rel-.html
Solubility
10 mM in DMSO
Smiles
CCCN1CC(CSC)C[C@]2([H])CC(NN=C3)=C3C[C@@]12[H]
Molecular Formula
C15H25N3S
Molecular Weight
279.44
References & Citations
[1]Robertson, David W., et al. TREATMENT OF FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME. WO 2001087308 A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY428394 100 µg
TRIP15 (COPS2) (NM_001143887) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC403242-500 1x 500 µL
Dystrophin (DMD) (Marker of Duchenne and Becker Muscular Dystrophy) (DMD/3242), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details